Short-Duration was Cigna’s largest product and service line in fiscal 2025, bringing in $39.30B of $40.30B (98%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2021 | FY 2022 | FY 2025 |
|---|---|---|---|---|---|---|
| Short-Duration | — | $39.30B | ||||
| Short-Duration Contracts | $36.90B | — | ||||
| Premiumsearnednet | — | — | ||||
| U.S. Medical Premiums | — | — | ||||
| Domestic Disability, Life & Accident Premiums | — | — | ||||
| Stop Loss | — | — | ||||
| Long-Duration | — | $1.00B | ||||
| Long-Duration Contracts | $3.00B | — | ||||
| Other | — | — | ||||
| Other Premiums | — | — | ||||
| Total | $39.90B | $40.30B |
Cigna brought in $40.30B from its two product and service lines in fiscal 2025, the year ended December 31, 2025. Cigna regrouped these lines after fiscal 2022, so the total does not compare directly with that year's $39.90B. Short-Duration was the largest at $39.30B (97.5%), ahead of Long-Duration at $1.00B (2.5%).
Cigna began breaking out Short-Duration in fiscal 2025 and Long-Duration in fiscal 2025. Cigna stopped reporting Short-Duration Contracts ($36.90B in fiscal 2022) and Long-Duration Contracts ($3.00B in fiscal 2022) as separate lines.
Cigna Healthcare was Cigna’s largest segment in fiscal 2025, bringing in $18.85B of $19.14B (98%).
| Segment | FY 2016 | FY 2017 | FY 2018 | FY 2020 | FY 2022 | FY 2025 |
|---|---|---|---|---|---|---|
| Evernorth Health Services | — | — | ||||
| U.S. Medical | — | — | ||||
| Cigna Healthcare | $15.20B | $18.85B | ||||
| Premiumsearnednet | — | — | ||||
| Other Operations | $1.60B | $288.00M | ||||
| Total | $16.80B | $19.14B |
Cigna brought in $19.14B from its two segments in fiscal 2025, the year ended December 31, 2025. That is less than the $40.30B it reports by product and service, so these segments do not cover all of its revenue. Cigna Healthcare was the largest at $18.85B (98.5%), ahead of Other Operations at $288.00M (1.5%).
U.S. Healthcare was Cigna’s largest segment in fiscal 2025, bringing in $18.85B of $22.98B (82%).
| Subsegments | FY 2021 | FY 2022 | FY 2025 |
|---|---|---|---|
| U.S. Healthcare | $15.20B | $18.85B | |
| International Health | $2.91B | $4.13B | |
| Divested International Businesses | $1.60B | — | |
| Other Operations Excluding Divested International Businesses | $225.00M | — | |
| Other | — | — | |
| Total | $19.93B | $22.98B |
Cigna brought in $22.98B from its two segments in fiscal 2025, the year ended December 31, 2025. That is less than the $40.30B it reports by product and service, so these segments do not cover all of its revenue. U.S. Healthcare was the largest at $18.85B (82.0%), ahead of International Health at $4.13B (18.0%).
Compared with fiscal 2022, the previous year with figures, International Health grew 42.0% to $4.13B and U.S. Healthcare grew 24.0% to $18.85B. Some of that change comes from Cigna regrouping its segments.
Cigna stopped reporting Divested International Businesses ($1.60B in fiscal 2022) and Other Operations Excluding Divested International Businesses ($225.00M in fiscal 2022) as separate segments.
Cigna (CI) reports its revenue by product and service, by segment and by subsegments. In fiscal 2025, Short-Duration was its largest product and service line, bringing in $39.30B (97.5% of the total), followed by Long-Duration at $1.00B (2.5%).
Short-Duration was Cigna's largest product and service line in fiscal 2025, bringing in $39.30B, or 97.5% of the $40.30B total across its two product and service lines.
Cigna Healthcare was Cigna's largest segment in fiscal 2025, bringing in $18.85B, or 98.5% of the $19.14B total across its two segments.
Every figure comes from Cigna's annual financial filings, as reported. Each line keeps the name Cigna gives it, and years follow its fiscal calendar.
Cigna's revenue by product and service goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.